New staining technique could sharpen healing assessment in IBD

NCT ID NCT07710287

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests whether a new laboratory method—staining for a protein called claudin 2—can more accurately measure healing in the gut of people with ulcerative colitis or Crohn's disease. Researchers will compare this method with standard scoring systems and track whether it predicts relapses, hospital stays, or surgery over one year. The goal is to improve how doctors assess disease activity and guide treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate way to measure healing in IBD, helping predict relapses and guide treatment decisions.
What could go wrong
This is an observational study, not a treatment trial. The new method may not prove more accurate than existing scores, and results may not change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gastroenterology IRCCS San Donato Policlinic

    RECRUITING

    San Donato Milanese, Mi, 20097, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.